Filter Characteristics Influencing Circulating Tumor Cell Enrichment from Whole Blood

被引:150
作者
Coumans, Frank A. W. [1 ]
van Dalum, Guus [1 ]
Beck, Markus [1 ]
Terstappen, Leon W. M. M. [1 ]
机构
[1] Univ Twente, MIRA Inst, NL-7500 AE Enschede, Netherlands
基金
欧洲研究理事会;
关键词
PERIPHERAL-BLOOD; CANCER-PATIENTS; SURVIVAL; CHEMOTHERAPY; PREDICT; ENUMERATION; PROGRESSION; EXPRESSION; MARKERS;
D O I
10.1371/journal.pone.0061770
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
A variety of filters assays have been described to enrich circulating tumor cells (CTC) based on differences in physical characteristics of blood cells and CTC. In this study we evaluate different filter types to derive the properties of the ideal filter for CTC enrichment. Between 0.1 and 10 mL of whole blood spiked with cells from tumor cell lines were passed through silicon nitride microsieves, polymer track-etched filters and metal TEM grids with various pore sizes. The recovery and size of 9 different culture cell lines was determined and compared to the size of EpCAM+CK+CD45-DNA+CTC from patients with metastatic breast, colorectal and prostate cancer. The 8 mm track-etched filter and the 5 mm microsieve had the best performance on MDA-231, PC3-9 and SKBR-3 cells, enriching>80% of cells from whole blood. TEM grids had poor recovery of similar to 25%. Median diameter of cell lines ranged from 10.9-19.0 mu m, compared to 13.1, 10.7, and 11.0 mu m for breast, prostate and colorectal CTC, respectively. The 11.4 mu m COLO-320 cell line had the lowest recovery of 17%. The ideal filter for CTC enrichment is constructed of a stiff, flat material, is inert to blood cells, has at least 100,000 regularly spaced 5 mu m pores for 1 ml of blood with a <= 10% porosity. While cell size is an important factor in determining recovery, other factors must be involved as well. To evaluate a filtration procedure, cell lines with a median size of 11-13 mu m should be used to challenge the system.
引用
收藏
页数:12
相关论文
共 43 条
[1]
Adams D, 2011, ISOLATION CIRCULATIN
[2]
Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients [J].
Alix-Panabières, C ;
Rebillard, X ;
Brouillet, JP ;
Barbotte, E ;
Iborra, F ;
Segui, B ;
Maudelonde, T ;
Jolivet-Reynaud, C ;
Vendrell, JP .
CLINICAL CHEMISTRY, 2005, 51 (08) :1538-1541
[3]
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[4]
Confocal Images of Circulating Tumor Cells Obtained Using a Methodology and Technology That Removes Normal Cells [J].
Balasubramanian, Priya ;
Yang, Liying ;
Lang, James C. ;
Jatana, Kris R. ;
Schuller, David ;
Agrawal, Amit ;
Zborowski, Maciej ;
Chalmers, Jeffrey J. .
MOLECULAR PHARMACEUTICS, 2009, 6 (05) :1402-1408
[5]
All circulating EpCAM+CK+CD45-objects predict overall survival in castration-resistant prostate cancer [J].
Coumans, F. A. W. ;
Doggen, C. J. M. ;
Attard, G. ;
de Bono, J. S. ;
Terstappen, L. W. M. M. .
ANNALS OF ONCOLOGY, 2010, 21 (09) :1851-1857
[6]
Filtration Parameters Influencing Circulating Tumor Cell Enrichment from Whole Blood [J].
Coumans, Frank A. W. ;
van Dalum, Guus ;
Beck, Markus ;
Terstappen, Leon W. M. M. .
PLOS ONE, 2013, 8 (04)
[7]
Challenges in the Enumeration and Phenotyping of CTC [J].
Coumans, Frank A. W. ;
Ligthart, Sjoerd T. ;
Uhr, Jonathan W. ;
Terstappen, Leon W. M. M. .
CLINICAL CANCER RESEARCH, 2012, 18 (20) :5711-5718
[8]
Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[9]
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer [J].
de Bono, Johann S. ;
Scher, Howard I. ;
Montgomery, R. Bruce ;
Parker, Christopher ;
Miller, M. Craig ;
Tissing, Henk ;
Doyle, Gerald V. ;
Terstappen, Leon W. W. M. ;
Pienta, Kenneth J. ;
Raghavan, Derek .
CLINICAL CANCER RESEARCH, 2008, 14 (19) :6302-6309
[10]
Circulating tumor cells: the Grand Challenge [J].
den Toonder, Jaap .
LAB ON A CHIP, 2011, 11 (03) :375-377